Tokyo Tape
Sign in
← Oncolys BioPharma

Half-year report · Q2

4588.TEDINET S100WI59
Period2025-01-01 → 2025-06-30
Filed2025-08-08
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 45
MetricValuePeriodScopeSource row
Revenue¥29m2025-01-01 → 2025-06-30StandaloneNet sales
Revenue¥31m2024-01-01 → 2024-12-31StandaloneNet sales (5-year summary)
Revenue¥31m2024-01-01 → 2024-06-30StandaloneNet sales
Operating income−¥1.3bn2025-01-01 → 2025-06-30StandaloneOperating income
Operating income−¥793m2024-01-01 → 2024-06-30StandaloneOperating income
Ordinary income−¥1.3bn2025-01-01 → 2025-06-30StandaloneOrdinary income
Ordinary income−¥1.7bn2024-01-01 → 2024-12-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥753m2024-01-01 → 2024-06-30StandaloneOrdinary income
Profit before tax−¥1.3bn2025-01-01 → 2025-06-30StandaloneIncome before income taxes
Profit before tax−¥753m2024-01-01 → 2024-06-30StandaloneIncome before income taxes
Net income−¥1.3bn2025-01-01 → 2025-06-30StandaloneProfit loss
Net income−¥1.7bn2024-01-01 → 2024-12-31StandaloneNet income loss (5-year summary)
Net income−¥755m2024-01-01 → 2024-06-30StandaloneProfit loss
Total assets¥1.9bnat 2025-06-30StandaloneAssets
Total assets¥3.2bnat 2024-12-31StandaloneAssets
Total assets¥1.9bnat 2024-06-30StandaloneTotal assets (5-year summary)
Total liabilities¥493mat 2025-06-30StandaloneLiabilities
Total liabilities¥447mat 2024-12-31StandaloneLiabilities
Net assets / equity¥1.4bnat 2025-06-30StandaloneNet assets
Net assets / equity¥2.8bnat 2024-12-31StandaloneNet assets
Net assets / equity¥1.4bnat 2024-06-30StandaloneNet assets (5-year summary)
Cash and deposits¥1.4bnat 2025-06-30StandaloneCash and deposits
Cash and deposits¥2.4bnat 2024-12-31StandaloneCash and deposits
Cash & equivalents¥1.1bnat 2025-06-30StandaloneCash and cash equivalents
Cash & equivalents¥2.2bnat 2024-12-31StandaloneCash and cash equivalents
Cash & equivalents¥872mat 2024-06-30StandaloneCash and cash equivalents
Cash & equivalents¥1.3bnat 2023-12-31vStandaloneCash and cash equivalents
Operating cash flow−¥1.0bn2025-01-01 → 2025-06-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥2.0bn2024-01-01 → 2024-12-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥1.1bn2024-01-01 → 2024-06-30StandaloneNet cash provided by used in operating activities
Investing cash flow−¥5m2025-01-01 → 2025-06-30StandaloneNet cash provided by used in investment activities
Investing cash flow−¥5m2024-01-01 → 2024-12-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥1m2024-01-01 → 2024-06-30StandaloneNet cash provided by used in investment activities
Financing cash flow¥42m2025-01-01 → 2025-06-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥2.9bn2024-01-01 → 2024-12-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥686m2024-01-01 → 2024-06-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥-52.852025-01-01 → 2025-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-77.172024-01-01 → 2024-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-36.962024-01-01 → 2024-06-30StandaloneBasic earnings loss per share (5-year summary)
Equity ratio74.1%at 2025-06-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio85.8%at 2024-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio74.7%at 2024-06-30StandaloneEquity to asset ratio (5-year summary)
Shares issued24,961,600at 2025-06-30StandaloneTotal number of issued shares (5-year summary)
Shares issued24,961,600at 2024-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued20,961,600at 2024-06-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 434
ItemContextValueUnit
Cost of salesCurrentYTDDuration_NonConsolidatedMember－JPY
Gross profitPrior1YTDDuration_NonConsolidatedMember31384000JPY
Gross profitCurrentYTDDuration_NonConsolidatedMember28546000JPY
Selling general and administrative expensesPrior1YTDDuration_NonConsolidatedMember824755000JPY
Selling general and administrative expensesCurrentYTDDuration_NonConsolidatedMember1295673000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember-793371000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember-1267127000JPY
Interest income noiPrior1YTDDuration_NonConsolidatedMember1047000JPY
Interest income noiCurrentYTDDuration_NonConsolidatedMember1824000JPY
Dividends income noiPrior1YTDDuration_NonConsolidatedMember5000JPY
Dividends income noiCurrentYTDDuration_NonConsolidatedMember3000JPY
Foreign exchange gains noiPrior1YTDDuration_NonConsolidatedMember48518000JPY
Foreign exchange gains noiCurrentYTDDuration_NonConsolidatedMember－JPY
Other noiPrior1YTDDuration_NonConsolidatedMember22000JPY
Other noiCurrentYTDDuration_NonConsolidatedMember27000JPY
Non operating incomePrior1YTDDuration_NonConsolidatedMember49593000JPY
Non operating incomeCurrentYTDDuration_NonConsolidatedMember1854000JPY
Interest expenses noePrior1YTDDuration_NonConsolidatedMember2185000JPY
Interest expenses noeCurrentYTDDuration_NonConsolidatedMember2289000JPY
Amortization of restricted stock remuneration noePrior1YTDDuration_NonConsolidatedMember2183000JPY
Amortization of restricted stock remuneration noeCurrentYTDDuration_NonConsolidatedMember5030000JPY
Foreign exchange losses noePrior1YTDDuration_NonConsolidatedMember－JPY
Foreign exchange losses noeCurrentYTDDuration_NonConsolidatedMember39061000JPY
Share acquisition rights issuance costs noePrior1YTDDuration_NonConsolidatedMember2310000JPY
Share acquisition rights issuance costs noeCurrentYTDDuration_NonConsolidatedMember－JPY
Stock issuance cost noePrior1YTDDuration_NonConsolidatedMember2466000JPY
Stock issuance cost noeCurrentYTDDuration_NonConsolidatedMember－JPY
Other noePrior1YTDDuration_NonConsolidatedMember73000JPY
Other noeCurrentYTDDuration_NonConsolidatedMember－JPY
Non operating expensesPrior1YTDDuration_NonConsolidatedMember9219000JPY
Non operating expensesCurrentYTDDuration_NonConsolidatedMember46381000JPY
Ordinary incomePrior1YTDDuration_NonConsolidatedMember-752997000JPY
Ordinary incomeCurrentYTDDuration_NonConsolidatedMember-1311654000JPY
Income before income taxesPrior1YTDDuration_NonConsolidatedMember-752997000JPY
Income before income taxesCurrentYTDDuration_NonConsolidatedMember-1311654000JPY
Income taxes currentPrior1YTDDuration_NonConsolidatedMember1871000JPY
Income taxes currentCurrentYTDDuration_NonConsolidatedMember1576000JPY
Income taxesPrior1YTDDuration_NonConsolidatedMember1871000JPY
Income taxesCurrentYTDDuration_NonConsolidatedMember1576000JPY
Profit lossPrior1YTDDuration_NonConsolidatedMember-754868000JPY
Profit lossCurrentYTDDuration_NonConsolidatedMember-1313230000JPY
Income before income taxesPrior1YTDDuration_NonConsolidatedMember-752997000JPY
Income before income taxesCurrentYTDDuration_NonConsolidatedMember-1311654000JPY
Depreciation and amortization ope cfPrior1YTDDuration_NonConsolidatedMember－JPY
Depreciation and amortization ope cfCurrentYTDDuration_NonConsolidatedMember52000JPY
Amortization of restricted stock remuneration ope cfPrior1YTDDuration_NonConsolidatedMember2183000JPY
Amortization of restricted stock remuneration ope cfCurrentYTDDuration_NonConsolidatedMember5030000JPY
Share based compensation expenses ope cfPrior1YTDDuration_NonConsolidatedMember6862000JPY
Share based compensation expenses ope cfCurrentYTDDuration_NonConsolidatedMember10308000JPY
Increase decrease in provision for retirement benefits ope cfPrior1YTDDuration_NonConsolidatedMember-1109000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2024-12-31pass
balance sheet identitynon_consolidated 2025-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2024-12-31pass
statement vs summary · net assetsnon_consolidated 2025-06-30pass
statement vs summary · operating cash flownon_consolidated 2024-01-01/2024-06-30pass
statement vs summary · operating cash flownon_consolidated 2025-01-01/2025-06-30pass
statement vs summary · revenuenon_consolidated 2024-01-01/2024-06-30pass
statement vs summary · revenuenon_consolidated 2025-01-01/2025-06-30pass
statement vs summary · total assetsnon_consolidated 2024-12-31pass
statement vs summary · total assetsnon_consolidated 2025-06-30pass